232 related articles for article (PubMed ID: 29845685)
1. Significance of postmenopausal uterine leiomyomas: Focus on variants.
Oi Y; Katayama K; Hirata G; Ishidera Y; Yoshida H; Shigeta H
J Obstet Gynaecol Res; 2018 Aug; 44(8):1445-1450. PubMed ID: 29845685
[TBL] [Abstract][Full Text] [Related]
2. Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma.
Tanioka S; Asano R; Wakabayashi R; Hayashi H; Shigeta H
BMC Womens Health; 2022 Aug; 22(1):346. PubMed ID: 35974345
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
Strissel PL; Swiatek J; Oppelt P; Renner SP; Beckmann MW; Strick R
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):42-7. PubMed ID: 17646097
[TBL] [Abstract][Full Text] [Related]
4. Assessment of fluorodeoxyglucose uptake by leiomyomas in relation to histopathologic subtype and the menstrual state.
Yoshida Y; Tsujikawa T; Kurokawa T; Tsuji T; Imamura Y; Fujibayashi Y; Okazawa H; Kotsuji F
J Comput Assist Tomogr; 2009; 33(6):877-81. PubMed ID: 19940654
[TBL] [Abstract][Full Text] [Related]
5. Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance.
Filip G; Balzano A; Cagnacci A
Minerva Ginecol; 2019 Jun; 71(3):177-181. PubMed ID: 30486633
[TBL] [Abstract][Full Text] [Related]
6. [Histological types of uterine fibroids in reproductive age and postmenopausal women].
Kadlecová J; Hudeček R; Mekiňová L; Ventruba P; Jandáková E
Ceska Gynekol; 2015 Oct; 80(5):360-4. PubMed ID: 26606122
[TBL] [Abstract][Full Text] [Related]
7. Frequency of endometriosis and adenomyosis in patients with leiomyomas, gynecologic premalignant, and malignant neoplasias.
Nomelini RS; Ferreira FA; Borges RC; Adad SJ; Murta EF
Clin Exp Obstet Gynecol; 2013; 40(1):40-4. PubMed ID: 23724504
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological characteristics, pathological reevaluation and recurrence patterns of cellular leiomyomas: a retrospective study in 76 patients.
Rothmund R; Kurth RR; Lukasinski NM; Huebner M; Hartkopf A; Wallwiener M; Staebler A; Brucker SY; Taran FA
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):358-61. PubMed ID: 24176540
[TBL] [Abstract][Full Text] [Related]
9. Relationship of myoma cell size and menopausal status in small uterine leiomyomas.
Cramer SF; Marchetti C; Freedman J; Padela A
Arch Pathol Lab Med; 2000 Oct; 124(10):1448-53. PubMed ID: 11035573
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women.
Palomba S; Orio F; Russo T; Falbo A; Tolino A; Lombardi G; Cimini V; Zullo F
Fertil Steril; 2005 Jul; 84(1):154-61. PubMed ID: 16009171
[TBL] [Abstract][Full Text] [Related]
11. The relation of fibrous degeneration to menopausal status in small uterine leiomyomas with evidence for postmenopausal origin of seedling myomas.
Cramer SF; Horiszny J; Patel A; Sigrist S
Mod Pathol; 1996 Jul; 9(7):774-80. PubMed ID: 8832561
[TBL] [Abstract][Full Text] [Related]
12. Fracture risk and bone density of peri- and early postmenopausal women with uterine leiomyomas.
Randell KM; Honkanen RJ; Tuppurainen MT; Kröger H; Jurvelin JS; Saarikoski S
Maturitas; 2006 Feb; 53(3):333-42. PubMed ID: 16019169
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma.
Higashijima T; Kataoka A; Nishida T; Yakushiji M
Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):169-73. PubMed ID: 8886702
[TBL] [Abstract][Full Text] [Related]
14. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
Parker WH; Fu YS; Berek JS
Obstet Gynecol; 1994 Mar; 83(3):414-8. PubMed ID: 8127535
[TBL] [Abstract][Full Text] [Related]
15. The nonrandom regional distribution of uterine leiomyomas: a clue to histogenesis?
Cramer SF; Patel A
Hum Pathol; 1992 Jun; 23(6):635-8. PubMed ID: 1592385
[TBL] [Abstract][Full Text] [Related]
16. Benign female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical and MDM2 fluorescence in situ hybridization study of 44 conventional lipoleiomyomas and lipoleiomyoma variants.
Swanson AA; Michal M; Xing D; Židlík V; Cheek-Norgan EH; Keeney ME; Keeney GL; Sukov WR; Gupta S; Nucci MR; Schoolmeester JK
Hum Pathol; 2023 Dec; 142():51-61. PubMed ID: 37972871
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological changes of uterine leiomyomas after GnRH agonist therapy.
Grigoriadis C; Papaconstantinou E; Mellou A; Hassiakos D; Liapis A; Kondi-Pafiti A
Clin Exp Obstet Gynecol; 2012; 39(2):191-4. PubMed ID: 22905461
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
[TBL] [Abstract][Full Text] [Related]
19. Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.
Palomba S; Sena T; Morelli M; Noia R; Zullo F; Mastrantonio P
Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):199-201. PubMed ID: 11950491
[TBL] [Abstract][Full Text] [Related]
20. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues.
Colgan TJ; Pendergast S; LeBlanc M
Hum Pathol; 1993 Oct; 24(10):1073-7. PubMed ID: 8406417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
